Table 2 Basal clinical and CMR characteristics of MVP cVA and MVP noVA
MAD cVA (23 patient) | MAD noVA (19 patient) | P value | |
|---|---|---|---|
Age (± SD) | 46.6 ± 13.0 | 49.6 ± 17.8 | 0.198 |
Male gender (%) | 10 (43%) | 11 (57%) | 0.887 |
BMI (± SD) | 26.4 ± 4.5 | 24.1 ± 4.7 | 0.612 |
BSA (m2 ± SD) | 1.7 ± 0.2 | 1.8 ± 0.3 | 0.452 |
EDV (ml ± SD) | 181.4 ± 48.2 | 184.3 ± 46.1 | 0.468 |
EDVi (ml/m2 ± SD) | 98.0 ± 25.9 | 98.4 ± 29.2 | 0.421 |
ESV (ml ± SD) | 79.6 ± 25.1 | 83.2 ± 34.2 | 0.537 |
EF (% ± SD) | 55.9 ± 8.4 | 57.2 ± 6.8 | 0.833 |
LV mass (g/m2 ± SD) | 62.3 ± 12.4 | 71.9 ± 14.2 | 0.486 |
MAD length (mm ± SD) | 10.3 ± 4.5 [7.3–12.3] | 9.2 ± 4.4 [6.7–11.5] | 0.417 |
MR | |||
– Mild | 3 (13%) | 4 (21%) | |
– Moderate | 14 (61%) | 11 (58%) | |
– Severe | 6 (26%) | 4 (21%) | |
LGE | 18 (78%) | 8 (42%) | 0.0002 |
Native T1 mapping (ms (± SD) | |||
– Anterior wall | 1021 ± 54 | 1011 ± 93 | 0.634 |
– Anterolateral wall | 1052 ± 56 | 1051 ± 65 | 0.401 |
– Inferolateral wall | 1104 ± 63 | 1074 ± 63 | 0.026 |
– Inferior wall | 1116 ± 58 | 1087 ± 58 | 0.015 |
– Inferoseptal wall | 1085 ± 59 | 1082 ± 48 | 0.167 |
– Anteroseptal wall | 1062 ± 40 | 1054 ± 44 | 0.611 |
– Mean | 1083 ± 41 | 1044 ± 52 | 0.039 |
ECV (% ± SD) | |||
– Anterior wall | 0.27 ± 0.04 | 0.27 ± 0.04 | 0.336 |
– Anterolateral wall | 0.29 ± 0.03 | 0.29 ± 0.05 | 0.464 |
– Inferolateral wall | 0.31 ± 0.05 | 0.30 ± 0.04 | 0.221 |
– Inferior wall | 0.31 ± 0.03 | 0.30 ± 0.02 | 0.307 |
– Inferoseptal wall | 0.29 ± 0.03 | 0.29 ± 0.04 | 0.87 |
– Anteroseptal wall | 0.28 ± 0.04 | 0.30 ± 0.03 | 0.235 |
– Mean | 0.30 ± 0.04 | 0.29 ± 0.04 | 0.791 |
GLS (± SD) | − 18.2 ± 4.6 | − 25.1 ± 3.1 | 0.004 |
LS basal (± SD) | |||
– Anterior wall | − 17.0 ± 8.2 | − 17.9 ± 9.1 | 0.924 |
– Anterolateral wall | − 22.8 ± 8.3 | − 22.1 ± 7.4 | 0.288 |
– Inferolateral wall | − 21.1 ± 11.0 | − 24.9 ± 9.3 | 0.459 |
– Inferior wall | − 16.8 ± 7.9 | − 23.1 ± 7.0 | 0.007 |
– Inferoseptal wall | − 18.6 ± 6.3 | − 20.8 ± 9.8 | 0.245 |
– Anteroseptal wall | − 27.5 ± 13.1 | − 24.3 ± 8.1 | 0.718 |
– Mean | − 24.3 ± 8.1 | − 22.9 ± 9.1 | 0.341 |
LS mid-wall (± SD) | |||
– Anterior wall | − 25.8 ± 10.7 | − 26.2 ± 8.3 | 0.719 |
– Anterolateral wall | − 24.2 ± 7.3 | − 29.7 ± 7.6 | 0.63 |
– Inferolateral wall | − 30.8 ± 7.6 | − 26.5 ± 6.3 | 0.071 |
– Inferior wall | − 29.5 ± 6.8 | − 28.6 ± 6.1 | 0.76 |
– Inferoseptal wall | − 24.2 ± 7.3 | − 25.3 ± 7.2 | 0.994 |
– Anteroseptal wall | − 22.4 ± 8.2 | − 21.0 ± 7.6 | 0.183 |
– Mean | − 24.5 ± 7.2 | − 24.5 ± 8.4 | 0.147 |
LS apical (± SD) | |||
– Anterior wall | − 27.6 ± 13.9 | − 28.0 ± 11.2 | 0.679 |
– Septal wall | − 22.3 ± 8.0 | − 29.7 ± 12.6 | 0.154 |
– Inferior wall | − 27.0 ± 12.8 | − 29.7 ± 12.6 | 0.28 |
– Lateral wall | − 26.9 ± 7.0 | − 28.0 ± 7.0 | 0.253 |
– Mean | − 29.0 ± 10.9 | − 34.6 ± 11.0 | 0.131 |
CS basal (± SD) | |||
– Anterior wall | − 24.5 ± 5.4 | − 26.1 ± 6.5 | 0.315 |
– Anterolateral wall | − 25.8 ± 5.5 | − 25.6 ± 5.5 | 0.887 |
– Inferolateral wall | − 19.5 ± 7.6 | − 27.4 ± 7.5 | 0.0001 |
– Inferior wall | − 19.6 ± 6.2 | − 26.2 ± 6.6 | 0.0078 |
– Inferoseptal wall | − 23.1 ± 5.0 | − 24.4 ± 5.9 | 0.927 |
– Anteroseptal wall | − 23.1 ± 5.0 | − 26.1 ± 7.4 | 0.713 |
– Mean | − 22.4 ± 4.5 | − 24.7 ± 6.4 | 0.765 |
CS midventricular (± SD) | |||
– Anterior wall | − 20.7 ± 4.8 | − 20.3 ± 3.4 | 0.359 |
– Anterolateral wall | − 22.1 ± 6.7 | − 20.3 ± 4.3 | 0.21 |
– Inferolateral wall | − 14.7 ± 8.2 | − 18.9 ± 6.9 | 0.053 |
– Inferior wall | − 23.3 ± 8.1 | − 24.3 ± 7.5 | 0.526 |
– Inferoseptal wall | − 22.1 ± 6.9 | − 19.9 ± 5.5 | 0.273 |
– Anteroseptal wall | − 23.2 ± 5.2 | − 19.7 ± 9.9 | 0.245 |
– Mean | − 17.5 ± 4.7 | − 21.6 ± 3.1 | 0.041 |
CS apical (± SD) | |||
– Anterior wall | − 32.5 ± 16.1 | − 24.8 ± 7.2 | 0.579 |
– Septal | − 26.3 ± 32.0 | − 31.9 ± 8.0 | 0.097 |
– Inferior | − 38.6 ± 12.4 | − 35.0 ± 15.3 | 0.715 |
– Lateral | − 34.1 ± 20.2 | − 31.6 ± 4.4 | 0.614 |
– Mean | − 30.8 ± 8.6 | − 33.1 ± 5.4 | 0.561 |